FDA Inspection 1034876 — Nipro Pharma Corporation - Kagamiishi Plant

Nipro Pharma Corporation - Kagamiishi Plant — FEI 3010317053

The FDA completed an inspection of Nipro Pharma Corporation - Kagamiishi Plant on Dec 15, 2017 in Iwase-Gun. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 15, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Iwase-Gun (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.